Author details

Full Name

Amelia Palermo

Affiliation

ORCID

Career Start Year

2014

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36984873	Changes in Plasma Metabolic Signature upon Acute and Chronic Morphine Administration in Morphine-Tolerant Mice.	Metabolites	2023
36427778	Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets.	Drug Discovery Today	2023
37467751	Hydroxyproline metabolism enhances IFN-Î³-induced PD-L1 expression and inhibits autophagic flux.	Cell Chem Biol	2023
34930786	Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.	Cancer Discov	2022
35835746	Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension.	Nat Commun	2022
35669561	Editorial: OMICS-Based Approaches in Sports Research.	Frontiers in Molecular Biosciences	2022
36523655	Editorial: OMICS-based approaches in sports research volume II.		2022
34902144	Mass Spectrometry Imaging of Metabolites by Nanostructure Initiator Mass Spectrometry with Fluorinated Gold Nanoparticles.	Methods in Molecular Biology	2022
33284134	Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.	JCI Insight	2021
33483720	Cognitive analysis of metabolomics data for systems biology.	Nat Protoc	2021
35190800	Cloud-based archived metabolomics data: A resource for in-source fragmentation/annotation, meta-analysis and systems biology.	Anal Sci Adv	2020
32242660	Enhanced in-Source Fragmentation Annotation Enables Novel Data Independent Acquisition and Autonomous METLIN Molecular Identification.	Anal Chem	2020
33595331	Charting Metabolism Heterogeneity by Nanostructure Imaging Mass Spectrometry: From Biological Systems to Subcellular Functions.	Journal of the American Society for Mass Spectrometry	2020
31499075	Effects of transdermal administration of testosterone gel on the urinary steroid profile in hypogonadal men: Implications in antidoping analysis.	Steroids	2019
31822592	Metabolic rewiring of the hypertensive kidney.	Sci Signal	2019
29381867	METLIN: A Technology Platform for Identifying Knowns and Unknowns.	Anal Chem	2018
29893550	Autonomous Multimodal Metabolomics Data Integration for Comprehensive Pathway Analysis and Systems Biology.	Anal Chem	2018
29966083	Fluorinated Gold Nanoparticles for Nanostructure Imaging Mass Spectrometry.	ACS Nano	2018
28759864	Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography-mass spectrometry profiling: Relevance to doping control analysis.	Journal of Pharmaceutical and Biomedical Analysis	2017
28351627	Non-targeted LC-MS based metabolomics analysis of the urinary steroidal profile.	Analytica Chimica Acta	2017
26480899	In vitro evaluation of the effects of anti-fungals, benzodiazepines and non-steroidal anti-inflammatory drugs on the glucuronidation of 19-norandrosterone: implications on doping control analysis.	Drug Testing and Analysis	2016
24431005	Drug-drug interaction and doping, part 1: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene.	Drug Testing and Analysis	2014